ConductScience.org, home

Paper39802175

Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure.

Varzideh F and 6 others. J Mol Cell Cardiol Plus, 2023. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure. Papers, record 39802175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39802175

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure.
PubMed
Journal
J Mol Cell Cardiol Plus
PubMed
Year
2023
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2026-09-24
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Varzideh FFahimeh
2Mone PPasquale
3Salemme LLuigi
4Forzano IImma
5Cioppa AAngelo
6Tesorio TTullio
7Santulli GGaetano

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135852527Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.JAMA2022https://conductscience.org/library/papers/35852527PubMed
236556120Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure.J Clin Med2022https://conductscience.org/library/papers/36556120PubMed
327914658Searching for the perfect agent to improve cardiac contractility.Lancet2016https://conductscience.org/library/papers/27914658PubMed
421415352Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.Science2011https://conductscience.org/library/papers/21415352PubMed
536082222Effects of omecamtiv mecarbil on the contractile properties of skinned porcine left atrial and ventricular muscles.Front Physiol2022https://conductscience.org/library/papers/36082222PubMed
634643642Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial.JAMA Cardiol2022https://conductscience.org/library/papers/34643642PubMed
736722665Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.ESC Heart Fail2023https://conductscience.org/library/papers/36722665PubMed
821856480Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study.Lancet2011https://conductscience.org/library/papers/21856480PubMed
934498676Advances in the understanding of excitation-contraction coupling: the pulsing quest for drugs against heart failure and arrhythmias.Eur Heart J Cardiovasc Pharmacother2021https://conductscience.org/library/papers/34498676PubMed
1027012405Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.J Am Coll Cardiol2016https://conductscience.org/library/papers/27012405PubMed
1139802172Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword.J Mol Cell Cardiol Plus2023https://conductscience.org/library/papers/39802172PubMed
1236672863Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil.Genes (Basel)2023https://conductscience.org/library/papers/36672863PubMed
1321616079Cardiac myosin activation part 1: from concept to clinic.J Mol Cell Cardiol2011https://conductscience.org/library/papers/21616079PubMed
1433176437Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study.Circ Heart Fail2020https://conductscience.org/library/papers/33176437PubMed
1521856481The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.Lancet2011https://conductscience.org/library/papers/21856481PubMed
1619234787A novel approach to improve cardiac performance: cardiac myosin activators.Heart Fail Rev2009https://conductscience.org/library/papers/19234787PubMed
1728956314New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling.Adv Exp Med Biol2018https://conductscience.org/library/papers/28956314PubMed
1827914656Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.Lancet2016https://conductscience.org/library/papers/27914656PubMed
1937239022Characterization of Stimulatory Action on Voltage-Gated Na+ Currents Caused by Omecamtiv Mecarbil, Known to Be a Myosin Activator.Biomedicines2023https://conductscience.org/library/papers/37239022PubMed
2034015475Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.J Am Coll Cardiol2021https://conductscience.org/library/papers/34015475PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39802175

GET https://conductscience.org/api/papers/v1/39802175/authors